1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TEX13B CTRPv2 pan-cancer AAC 0.23 3e-10
mRNA CSTA CTRPv2 pan-cancer AAC 0.23 2e-08
mRNA TACSTD2 CTRPv2 pan-cancer AAC 0.23 6e-07
mRNA SH3TC2 CTRPv2 pan-cancer AAC 0.23 9e-08
mRNA GJB3 CTRPv2 pan-cancer AAC 0.24 1e-07
mRNA SPINT1 CTRPv2 pan-cancer AAC 0.24 6e-08
mRNA FAM9A CTRPv2 pan-cancer AAC 0.25 7e-12
mRNA XDH CTRPv2 pan-cancer AAC 0.26 8e-11
mRNA GPR87 CTRPv2 pan-cancer AAC 0.28 1e-08
mRNA IRF6 CTRPv2 pan-cancer AAC 0.31 1e-10
Download CSV